|
Title
|
|
|
|
Supporting clinical decision-making during the SARS-CoV-2 pandemic through a global research commitment : the TERAVOLT experience comment
| |
|
Author
|
|
|
|
| |
|
Abstract
|
|
|
|
| To understand the real impact of COVID-19 on cancer patients, an entirely new data collection effort was initiated within the Thoracic Cancers International COVID-19 Collaboration (TERAVOLT). TERAVOLT reported high mortality related to COVID-19 infection in thoracic cancer patients and identified several negative prognostic factors. In this commentary, we discuss the importance and limits of patient registries to support decision-making in thoracic cancer during the SARS-CoV-2 pandemic. |
| |
|
Language
|
|
|
|
English
| |
|
Source (journal)
|
|
|
|
Cancer cell. - Cambridge, Mass.
| |
|
Publication
|
|
|
|
Cambridge
:
Cell press
,
2020
| |
|
ISSN
|
|
|
|
1535-6108
| |
|
DOI
|
|
|
|
10.1016/J.CCELL.2020.10.002
| |
|
Volume/pages
|
|
|
|
38
:5
(2020)
, p. 602-604
| |
|
ISI
|
|
|
|
000589896200003
| |
|
Pubmed ID
|
|
|
|
33091381
| |
|
Full text (Publisher's DOI)
|
|
|
|
| |
|
Full text (publisher's version - intranet only)
|
|
|
|
| |
|